Bradley D. Gelfand, PhD, of UVA’s Center for Advanced Vision Science (IMAGE)
Caption
“These findings are an exciting example of the promise of drug repurposing, using existing medicines in new and unexpected ways,” said researcher Bradley D. Gelfand, PhD, of UVA’s Center for Advanced Vision Science. “Ultimately, the best way to test whether fluoxetine benefits macular degeneration is to run a prospective clinical trial.”
Credit
Dan Addison | UVA Communications
Usage Restrictions
May be used to accompany news coverage of the Prozac discovery. All other uses require express written permission from UVA Health.
License
Original content